{
    "id": "dbpedia_8095_0",
    "rank": 89,
    "data": {
        "url": "https://www.uventia.com/event/3rd-annual-genotoxic-impurities-summit-nitrosamines-beyond-2023/",
        "read_more_link": "",
        "language": "en",
        "title": "3rd Annual Genotoxic Impurities Summit: Nitrosamines & Beyond 2023",
        "top_image": "https://www.uventia.com/wp-content/uploads/2023/12/3rd-Annual-Genotoxic-Impurities-Nitrosamines-Beyond.jpg",
        "meta_img": "https://www.uventia.com/wp-content/uploads/2023/12/3rd-Annual-Genotoxic-Impurities-Nitrosamines-Beyond.jpg",
        "images": [
            "https://www.facebook.com/tr?id=1559551094520571&ev=PageView&noscript=1",
            "https://px.ads.linkedin.com/collect/?pid=6184833&fmt=gif",
            "https://www.uventia.com/wp-content/uploads/2020/10/UVENTIA-LOGO.png",
            "https://www.uventia.com/wp-content/uploads/2020/10/UVENTIA-LOGO.png",
            "https://www.uventia.com/wp-content/uploads/2020/10/UVENTIA-LOGO.png",
            "https://www.uventia.com/wp-content/uploads/2020/10/UVENTIA-LOGO.png",
            "https://www.uventia.com/wp-content/uploads/2023/12/3rd-Annual-Genotoxic-Impurities-Nitrosamines-Beyond.jpg",
            "http://www.uventia.com/wp-content/uploads/2020/10/time-zone.png",
            "http://www.uventia.com/wp-content/uploads/2020/10/language.png",
            "http://www.uventia.com/wp-content/uploads/2021/01/zoom.png",
            "https://www.uventia.com/wp-content/uploads/2023/12/Agenda-3GTI-300x300.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/plugins/revslider/public/assets/assets/dummy.png",
            "https://www.uventia.com/wp-content/uploads/2023/12/SP_SEQENS.png",
            "https://www.uventia.com/wp-content/uploads/2023/12/2nd-Annual-Genotoxic-Impurities-Nitrosamines-Beyond-952x579.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/08/Genotoxic-Impurities-Summit-Nitrosamines-Beyond-952x579.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/11/Gautier-Decock.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/11/Samuel-Conway.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/09/George-Johnson.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/09/Alyssa-Musso.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/11/Andrew-Poulton.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/09/Andreas-Czich.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/08/Mourad-F.-Rahi.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/08/Avital-Talya-Milenkiy.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/07/Leon-F.-Stankowski.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/07/Bruno-Spieldenner.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/07/Jasmin-Lott.jpg",
            "https://www.uventia.com/wp-content/uploads/2022/08/Susanne-Glowienke.jpg",
            "https://www.uventia.com/wp-content/uploads/2022/08/Mike-Urquhart.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/09/Patrick-Reichl.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/09/Reinhard-Stidl.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/08/Raphael-Nudelman.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/08/Michael-Burns.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/08/Lhasa-Limited-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2021/08/Michael-Burns-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/10/EDQM-Council-of-Europe-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/07/Bruno-Spieldenner-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/12/GSK-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2022/08/Mike-Urquhart-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/08/TEVA-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2021/08/Raphael-Nudelman-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/09/Swansea-University-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/09/George-Johnson-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/02/AstraZeneca-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/11/Andrew-Poulton-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2022/08/Pfizer-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/09/Alyssa-Musso-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/08/Sanofi-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/09/Andreas-Czich-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/06/SEQENS-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/11/Gautier-Decock-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2022/08/Susanne-Glowienke-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/02/Boehringer-Ingelheim-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/07/Jasmin-Lott-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/09/croma_est1976-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2021/09/Patrick-Reichl-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/09/Safetree-Consulting-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2021/09/Reinhard-Stidl-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2021/08/TEVA-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/08/Avital-Talya-Milenkiy-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/08/Preclintox-Services-LLC-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/08/Mourad-F.-Rahi-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/07/Charles-River-Laboratories-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/07/Leon-F.-Stankowski-85x85.jpg",
            "https://www.uventia.com/wp-content/uploads/2023/11/Becton-Dickinson-130x60.png",
            "https://www.uventia.com/wp-content/uploads/2023/11/Samuel-Conway-85x85.jpg",
            "http://www.uventia.com/wp-content/uploads/2020/10/time-zone.png",
            "http://www.uventia.com/wp-content/uploads/2020/10/language.png",
            "http://www.uventia.com/wp-content/uploads/2021/01/zoom.png",
            "https://www.uventia.com/wp-content/uploads/2023/12/SP_SEQENS.png",
            "https://www.uventia.com/wp-content/uploads/2020/11/Cleaning-Validation-Summit_M-952x579.jpg",
            "https://www.uventia.com/wp-content/uploads/2024/03/Annual-Genotoxic-Impurities-Nitrosamines-Beyond-952x579.jpg",
            "https://www.uventia.com/wp-content/uploads/2020/11/Combination-Products-Summit-952x579.jpg",
            "https://www.uventia.com/wp-content/uploads/2020/10/UVENTIA-LOGO.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2024-07-25T13:34:43+01:00",
        "summary": "",
        "meta_description": "Learn the best techniques and cutting-edge methods for reducing genotoxic and elemental impurities. Recording of 2 days event sessions [17 video sessions].",
        "meta_lang": "en",
        "meta_favicon": "https://www.uventia.com/wp-content/uploads/2024/07/cropped-uventia-32x32.png",
        "meta_site_name": "uventia",
        "canonical_link": "https://www.uventia.com/event/3rd-annual-genotoxic-impurities-summit-nitrosamines-beyond-2023/",
        "text": "The presentation will start with a short overview of the EDQM and how it fits in the European regulatory system.\n\nThe historical evolution from the outbreak of nitrosamines in June 2018 to today and the actions taken on the EU/EC/EMA regulatory level as well as at EDQM will be provided.\n\nFinally, the EDQM response to nitrosamines will be provided by detailing the actions undertaken and still ongoing within the three main tracks that are: the texts of the European Pharmacopoeia, the testing of batchs within the Official Medicines Control Laboratories and the Certification (CEP) procedure.\n\nEDQM, Council of Europe, FR\n\n◆ How N-nitrosamines might form within DS and DP and how to assess.\n\n◆ Experiences of Step 2 testing.\n\n◆ Steps taken when an N-nitrosamine and/or N-nitroso drug substance related impurity (NDSRI) is confirmed.\n\n◆ How GSK are assessing risk in R&D.\n\n◆ Reflections and looking forward.\n\nGSK, UK\n\n◆ The analysis of nitrosamines in drug products is well studied, but little is reported regarding the content of nitrosamines in pharmaceutical rubber.\n\n◆ Highly inconsistent results were obtained using traditional extraction techniques to evaluate the content of nitrosodimethylamine (NDMA) in rubber.\n\n◆ Evidence suggests that NDMA is formed in situ during (and after) extraction.\n\n◆ NDMA may not be present in the rubber in its native form, but may be generated by attempts to detect it.\n\nBD Technologies, USA"
    }
}